Article Details
Retrieved on: 2018-04-22 23:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors increased Teva Pharmaceutcl Inds Adr (TEVA) stake by 59.31% reported in 2017Q4 SEC filing. <b>Benchmark Capital</b> Advisors acquired 17,700 shares as Teva Pharmaceutcl Inds Adr (TEVA)'s stock declined 11.04%. The <b>Benchmark Capital</b> Advisors holds 47,544 shares with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here